Qadir MMF, Bhondeley M, Beatty W, et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight. 2021;6(16):e151551. Published 2021 Aug 23.
Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E. Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19 [published online ahead of print, 2023 May 22]. JAMA. 2023;10.1001/jama.2023.8674.
Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health. 2023;11:1170156. Published 2023 May 25.
Rahmati M, Yon DK, Lee SW, et al. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies. J Med Virol. 2023;95(6):e28833.
López-Hernández Y, Oropeza-Valdez JJ, García Lopez DA, et al. Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery. Front Mol Biosci. 2023;10:1100486. Published 2023 Mar 3.
Steenblock C, Toepfner N, Beuschlein F, et al. SARS-CoV-2 infection and its effects on the endocrine system [published online ahead of print, 2023 Mar 5]. Best Pract Res Clin Endocrinol Metab. 2023;101761.